EP1565200A4 - Nucleic acid corresponding protein entitled 24p4c12 useful in treatment and detection of cancer - Google Patents

Nucleic acid corresponding protein entitled 24p4c12 useful in treatment and detection of cancer

Info

Publication number: EP1565200A4
Authority: EP; European Patent Office
Prior art keywords: cancer; useful; detection; treatment; nucleic acid
Prior art date: 2002-11-27
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP02789937A

Other languages

German (de)

French (fr)

Other versions

EP1565200A2 (en

Inventor

Arthur B Raitano

Karen Jane Meyrick Morrison

Wangmao Ge

Pia M Challita-Eid

Aya Jakobovits

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Agensys Inc

Original Assignee

Agensys Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-11-27

Filing date

2002-11-27

Publication date

2009-06-24

2002-11-27 Application filed by Agensys Inc filed Critical Agensys Inc

2005-08-24 Publication of EP1565200A2 publication Critical patent/EP1565200A2/en

2009-06-24 Publication of EP1565200A4 publication Critical patent/EP1565200A4/en

Status Withdrawn legal-status Critical Current

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Urology & Nephrology (AREA)
Veterinary Medicine (AREA)
Immunology (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Molecular Biology (AREA)
Hematology (AREA)
Biomedical Technology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Physics & Mathematics (AREA)
Hospice & Palliative Care (AREA)
Oncology (AREA)
Gastroenterology & Hepatology (AREA)
Biotechnology (AREA)
Cell Biology (AREA)
Zoology (AREA)
Microbiology (AREA)
Marine Sciences & Fisheries (AREA)
Food Science & Technology (AREA)
Epidemiology (AREA)
Analytical Chemistry (AREA)
Biochemistry (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

EP02789937A 2002-11-27 2002-11-27 Nucleic acid corresponding protein entitled 24p4c12 useful in treatment and detection of cancer Withdrawn EP1565200A4 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
PCT/US2002/038264 WO2004050828A2 (en)	2002-11-27	2002-11-27	Nucleic acid corresponding protein entitled 24p4c12 useful in treatment and detection of cancer

Publications (2)

Publication Number	Publication Date
EP1565200A2 EP1565200A2 (en)	2005-08-24
EP1565200A4 true EP1565200A4 (en)	2009-06-24

Family

ID=32467113

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP02789937A Withdrawn EP1565200A4 (en)	2002-11-27	2002-11-27	Nucleic acid corresponding protein entitled 24p4c12 useful in treatment and detection of cancer

Country Status (6)

Country	Link
EP (1)	EP1565200A4 (en)
JP (1)	JP2006508163A (en)
AU (3)	AU2002352976B2 (en)
CA (1)	CA2503346C (en)
IL (1)	IL167892A (en)
WO (1)	WO2004050828A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP5518711B2 (en) *	2007-09-07	2014-06-11	アジェンシス，インコーポレイテッド	Antibodies and related molecules that bind to 24P4C12 protein
CA2754531A1 (en) *	2009-03-06	2010-09-30	Seattle Genetics, Inc.	Antibody drug conjugates (adc) that bind to 24p4c12 proteins
JP2013049646A (en) *	2011-08-30	2013-03-14	Tokyo Medical Univ	Cancer treatment
KR20180059922A (en) *	2015-10-02	2018-06-05	유니버시티 오브 코펜하겐	Small molecule blocking the histone leader domain
WO2017132279A1 (en)	2016-01-25	2017-08-03	Genentech, Inc.	Methods for assaying t-cell dependent bispecific antibodies
CN119086940A (en) *	2017-04-28	2024-12-06	朋友股份有限公司	Antigens and epitopes of allergic reactions

Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2000061746A1 (en) *	1999-04-12	2000-10-19	Agensys, Inc.	13 transmembrane protein expressed in prostate cancer
WO2001046258A2 (en) *	1999-12-23	2001-06-28	Incyte Genomics, Inc.	Transporters and ion channels

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4179337A (en)	1973-07-20	1979-12-18	Davis Frank F	Non-immunogenic polypeptides
US4235871A (en)	1978-02-24	1980-11-25	Papahadjopoulos Demetrios P	Method of encapsulating biologically active materials in lipid vesicles
JPS6023084B2 (en)	1979-07-11	1985-06-05	味の素株式会社	blood substitute
US4640835A (en)	1981-10-30	1987-02-03	Nippon Chemiphar Company, Ltd.	Plasminogen activator derivatives
US4722848A (en)	1982-12-08	1988-02-02	Health Research, Incorporated	Method for immunizing animals with synthetically modified vaccinia virus
US4501728A (en)	1983-01-06	1985-02-26	Technology Unlimited, Inc.	Masking of liposomes from RES recognition
US4496689A (en)	1983-12-27	1985-01-29	Miles Laboratories, Inc.	Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer
US5019369A (en)	1984-10-22	1991-05-28	Vestar, Inc.	Method of targeting tumors in humans
EP0206448B1 (en)	1985-06-19	1990-11-14	Ajinomoto Co., Inc.	Hemoglobin combined with a poly(alkylene oxide)
US4791192A (en)	1986-06-26	1988-12-13	Takeda Chemical Industries, Ltd.	Chemically modified protein with polyethyleneglycol
US4837028A (en)	1986-12-24	1989-06-06	Liposome Technology, Inc.	Liposomes with enhanced circulation time
US5225538A (en)	1989-02-23	1993-07-06	Genentech, Inc.	Lymphocyte homing receptor/immunoglobulin fusion proteins
US5703055A (en)	1989-03-21	1997-12-30	Wisconsin Alumni Research Foundation	Generation of antibodies through lipid mediated DNA delivery
DK0452457T3 (en)	1989-11-03	1998-03-02	Univ Vanderbilt	Method for in vivo removal of functional foreign genes
US5279833A (en)	1990-04-04	1994-01-18	Yale University	Liposomal transfection of nucleic acids into animal cells
US5204253A (en)	1990-05-29	1993-04-20	E. I. Du Pont De Nemours And Company	Method and apparatus for introducing biological substances into living cells
SE9002480D0 (en)	1990-07-23	1990-07-23	Hans Lilja	ASSAY OF FREE AND COMPLEXED PROSTATE-SPECIFIC ANTIGEN
EP0646178A1 (en)	1992-06-04	1995-04-05	The Regents Of The University Of California	expression cassette with regularoty regions functional in the mammmlian host
US5804566A (en)	1993-08-26	1998-09-08	The Regents Of The University Of California	Methods and devices for immunizing a host through administration of naked polynucleotides with encode allergenic peptides
US5679647A (en)	1993-08-26	1997-10-21	The Regents Of The University Of California	Methods and devices for immunizing a host against tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides
DK0735893T3 (en)	1993-09-14	2009-03-09	Pharmexa Inc	PAN DR-binding peptides to enhance the immune response
US5739118A (en)	1994-04-01	1998-04-14	Apollon, Inc.	Compositions and methods for delivery of genetic material
US5919652A (en)	1994-11-09	1999-07-06	The Regents Of The University Of California	Nucleic acid molecules comprising the prostate specific antigen (PSA) promoter and uses thereof
US5736524A (en)	1994-11-14	1998-04-07	Merck & Co.,. Inc.	Polynucleotide tuberculosis vaccine
US5962428A (en)	1995-03-30	1999-10-05	Apollon, Inc.	Compositions and methods for delivery of genetic material
US5922687A (en)	1995-05-04	1999-07-13	Board Of Trustees Of The Leland Stanford Junior University	Intracellular delivery of nucleic acids using pressure
CU22559A1 (en)	1996-01-17	1999-05-03	Ct Ingenieria Genetica Biotech	EXPRESSION SYSTEM OF HETEROLOGICAL ANTIGENS IN E. COLI AS FUSION PROTEINS
AU2203797A (en)	1996-03-11	1997-10-01	Epimmune, Inc.	Peptides with increased binding affinity for hla molecules
JP2000516090A (en)	1996-07-26	2000-12-05	スローン―ケッタリングインスティチュートフォーキャンサーリサーチ	Methods and reagents for genetic immunization
US5840501A (en)	1996-10-25	1998-11-24	Bayer Corporation	Determination of cPSA
JP2001512013A (en) *	1997-08-01	2001-08-21	ジェンセット	5'EST of secreted protein expressed in prostate
US6943235B1 (en) *	1999-04-12	2005-09-13	Agensys, Inc.	Transmembrane protein expressed in prostate cancer

2002
- 2002-11-27 EP EP02789937A patent/EP1565200A4/en not_active Withdrawn
- 2002-11-27 AU AU2002352976A patent/AU2002352976B2/en not_active Expired
- 2002-11-27 WO PCT/US2002/038264 patent/WO2004050828A2/en not_active Ceased
- 2002-11-27 CA CA2503346A patent/CA2503346C/en not_active Expired - Lifetime
- 2002-11-27 JP JP2004557078A patent/JP2006508163A/en active Pending
2005
- 2005-04-06 IL IL167892A patent/IL167892A/en active IP Right Grant
2008
- 2008-02-08 AU AU2008200628A patent/AU2008200628B2/en not_active Expired
2009
- 2009-08-07 AU AU2009208065A patent/AU2009208065B2/en not_active Expired

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2000061746A1 (en) *	1999-04-12	2000-10-19	Agensys, Inc.	13 transmembrane protein expressed in prostate cancer
WO2001046258A2 (en) *	1999-12-23	2001-06-28	Incyte Genomics, Inc.	Transporters and ion channels

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2004050828A2 *

Also Published As

Publication number	Publication date
JP2006508163A (en)	2006-03-09
WO2004050828A3 (en)	2004-12-09
AU2008200628B2 (en)	2009-05-07
AU2008200628A1 (en)	2008-03-06
CA2503346A1 (en)	2004-06-17
EP1565200A2 (en)	2005-08-24
CA2503346C (en)	2014-03-18
AU2002352976A1 (en)	2004-06-23
AU2009208065A1 (en)	2009-08-27
AU2002352976B2 (en)	2007-11-08
WO2004050828A2 (en)	2004-06-17
IL167892A (en)	2012-06-28
AU2009208065B2 (en)	2012-05-24

Publication	Publication Date	Title
AU2003243151A8 (en)	2004-03-03	Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer
WO2003087306A8 (en)	2006-10-05	Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer
EP1517606A4 (en)	2007-11-14	Nucleic acid and corresponding protein entitled 193p1e1b useful in treatment and detection of cancer
EP1622571A4 (en)	2012-05-02	Nucleic acids and corresponding proteins entitled 109p1d4 useful in treatment and detection of cancer
AU2002318112B2 (en)	2007-12-06	Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers
AU2002337696A8 (en)	2006-11-09	Detection of tumor rna in plasma and serum
PT1537140E (en)	2013-03-11	Nucleic acid and corresponding protein entitled 161p2f10b useful in treatment and detection of cancer
EP1372719A4 (en)	2007-02-07	Nucleic acid and corresponding protein entitled 125p5c8 useful in treatment and detection of cancer
EP1590437A4 (en)	2008-06-18	Nucleic acids and corresponding proteins entitled 254p1d6b useful in treatment and detection of cancer
AU2002246708A1 (en)	2002-08-12	Nucleic acid and encoded zinc transporter protein entitled 108p5h8 useful in treatment and detection of cancer
WO2002083917A8 (en)	2004-02-26	Nucleic acid and corresponding protein entitled 161p5c5 useful in treatment and detection of cancer
AU2001285018A1 (en)	2002-02-25	Nucleic acids and corresponding proteins entitled 83p2h3 and catrf2e11 useful in treatment and detection of cancer
EP1565200A4 (en)	2009-06-24	Nucleic acid corresponding protein entitled 24p4c12 useful in treatment and detection of cancer
EP1578980A4 (en)	2013-01-02	Nucleic acid and corresponding protein entitled 213p1f11 useful in treatment and detection of cancer
EP1539805A4 (en)	2005-11-16	Nucleic acids and corresponsing proteins entitled 101p3a11 or phor-1 useful in treatment and detection of cancer
AU2003268355A8 (en)	2004-03-29	Localization of human cytomegalovirus nucleic acids and proteins in human cancer cells
EP1399174A4 (en)	2004-11-17	Nucleic acid and corresponding protein entitled 121p1f1 useful in treatment and detection of cancer
ZA200501838B (en)	2006-11-29	Nucleic acid and corresponding protein entitled 98P4B6 useful in treatment and detection of cancer
IL164390A0 (en)	2005-12-18	Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer
AU2003263036A8 (en)	2004-03-19	Span-xb gene and protein for the diagnosis and treatment of cancer
AU2003217112A1 (en)	2003-09-29	Method and kit for detection of mutations in mitochondrial dna
HK1080113A (en)	2006-04-21	Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer
HK1076051A (en)	2006-01-06	Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer
AU2001286541A1 (en)	2002-02-25	Nucleic acids and corresponding proteins entitled phor1-a11 and phor1-f5d6 useful in treatment and detection of cancer
AU2002305170A1 (en)	2002-10-28	Nucleic acid and corresponding protein entitled 151p3d4 useful in treatment and detection of cancer

Legal Events

Date	Code	Title	Description
2005-07-08	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2005-08-24	17P	Request for examination filed	Effective date: 20050421
2005-08-24	AK	Designated contracting states	Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR
2005-08-24	AX	Request for extension of the european patent	Extension state: AL LT LV MK RO SI
2006-03-22	DAX	Request for extension of the european patent (deleted)
2009-06-24	A4	Supplementary search report drawn up and despatched	Effective date: 20090525
2009-10-28	17Q	First examination report despatched	Effective date: 20090923
2010-01-20	RAP1	Party data changed (applicant data changed or rights of an application transferred)	Owner name: AGENSYS, INC.
2015-03-04	GRAP	Despatch of communication of intention to grant a patent	Free format text: ORIGINAL CODE: EPIDOSNIGR1
2015-04-01	INTG	Intention to grant announced	Effective date: 20150304
2015-12-11	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2016-01-13	18D	Application deemed to be withdrawn	Effective date: 20150715